As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…
HOME > ACADEMIA
ACADEMIA
- Saitama Medical Univ. Develops Jointly with Daiichi Sankyo New Antibody with Potential Application in Treatment of FOP
October 26, 2016
- 6 Drug Makers to Participate in “Drug Redirection Program” for Compounds in Development Limbo: Univ. of Tokyo’s Initiative
October 18, 2016
- Osteoporosis Experts Express “Shock” at Discontinuation of Development of Odanacatib
October 7, 2016
- Amendment to Personal Info Law Shouldn’t Stymie Epidemiology Studies: Doctors
September 27, 2016
- Japan Hypertension Society to Soon Report VART Paper Retraction in Publication
September 26, 2016
- Univ. of Tokyo to Launch Probe into 22 Scientific Papers after Data Manipulation Claims
September 23, 2016
- Japan, Korea NCCs to Collaborate in Personnel Exchanges, Joint Research
September 7, 2016
- JAMS Pres. Takaku, Global Scientists Call for HPV Vaccine Recommendation
August 30, 2016
- Japan Hypertension Society to Retract Diovan Paper on VART Study
August 16, 2016
- Japan Society Draws Up New Guidelines on Depression
August 16, 2016
- 3 Scientific Societies to Set Up HBOC Body to Build BRCA Gene Database
August 4, 2016
- Scientific Panel Fails to Reach Consensus on Withdrawal of Antiresorptive Agents Before Oral Invasive Surgery
July 27, 2016
- New Enuresis Treatment Guidelines Recommend Desmopressin as First-Line Pharmacotherapy: Japanese Society on Enuresis
July 26, 2016
- Regenerative Medicine Society to Introduce Treatment Compensation System in November
July 26, 2016
- Japanese Society of Nephrology Aims to Promote Development through “Surrogate Endpoints”; Hopes to Draft Guidelines in FY2017
July 22, 2016
- 1st Line Statins Likely to Be Recommended for Pediatric Familial Hypercholesterolemia
July 21, 2016
- New Atherosclerosis Guidelines Likely to Add PCSK9 Inhibitors for Primary Prevention of CAD in Familial Hypercholesterolemia
July 20, 2016
- Japan Oncology Society Warns of Privately Imported Opdivo, Yervoy
July 19, 2016
- JSGO Will Revise Guidelines to Recommend Bevacizumab in Treatment of Stage IVB/Relapsed Cervical Cancer
July 14, 2016
- Biosimilar Use Should Be Required Under Publicly Funded Systems: JSGM Pres.
July 13, 2016
ページ
Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…
To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…
While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…